Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy Meeting Abstract


Authors: Geyer, M.; Park, J.; Rivière, I.; Senechal, B.; Hsu, M.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R.
Abstract Title: Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy
Meeting Title: 4th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 16
Issue: Suppl. 2
Meeting Dates: 2016 Sep 7-10
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2016-09-01
Start Page: S48
Language: English
ACCESSION: 117709162
DOI: 10.1016/j.clml.2016.07.069
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Accession Number: 117709162 -- Entry Date: In Process -- Revision Date: 20160829 -- Publication Type: Meeting Abstract: CLL-123 -- Supplement Title: Sep2016 Supplement 2 -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: cin20
Altmetric Score
MSK Authors
  1. Meier Hsu
    104 Hsu
  2. Renier J Brentjens
    195 Brentjens
  3. Jae Hong Park
    145 Park
  4. Michel W J Sadelain
    456 Sadelain
  5. Isabelle C Riviere
    164 Riviere
  6. Xiuyan Wang
    65 Wang
  7. Terence John Purdon
    35 Purdon
  8. Mark Blaine Geyer
    21 Geyer